148 related articles for article (PubMed ID: 11877365)
1. Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation.
Bruban V; Estato V; Schann S; Ehrhardt JD; Monassier L; Renard P; Scalbert E; Feldman J; Bousquet P
Circulation; 2002 Mar; 105(9):1116-21. PubMed ID: 11877365
[TBL] [Abstract][Full Text] [Related]
2. Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.
Bruban V; Feldman J; Greney H; Dontenwill M; Schann S; Jarry C; Payard M; Boutin J; Scalbert E; Pfeiffer B; Renard P; Vanhoutte P; Bousquet P
Br J Pharmacol; 2001 May; 133(2):261-6. PubMed ID: 11350862
[TBL] [Abstract][Full Text] [Related]
3. Comparison of renal sympathetic baroreflex effects of rilmenidine and alpha-methylnoradrenaline in the ventrolateral medulla of the rabbit.
Head GA; Burke SL
J Hypertens; 2000 Sep; 18(9):1263-76. PubMed ID: 10994758
[TBL] [Abstract][Full Text] [Related]
4. Opposite to alpha2-adrenergic agonists, an imidazoline I1 selective compound does not influence reflex bradycardia in rabbits.
Sy GY; Bousquet P; Feldman J
Auton Neurosci; 2006 Jul; 128(1-2):19-24. PubMed ID: 16464646
[TBL] [Abstract][Full Text] [Related]
5. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
Wang X; Li G; Abdel-Rahman AA
Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
[TBL] [Abstract][Full Text] [Related]
6. Relative importance of medullary brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetized rabbit.
Head GA; Burke SL
J Hypertens; 1998 Apr; 16(4):503-17. PubMed ID: 9797196
[TBL] [Abstract][Full Text] [Related]
7. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
Chan CK; Burke SL; Head GA
J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
[TBL] [Abstract][Full Text] [Related]
8. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
Head GA; Burke SL; Chan CK
J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and central antihypertensive drugs: one more difference between catecholamines and imidazolines.
Sy GY; Bruban V; Bousquet P; Feldman J
Hypertension; 2001 Feb; 37(2):246-9. PubMed ID: 11230279
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide discriminates the sites and mechanisms of action of centrally acting anti-hypertensive drugs in rabbits.
Sy GY; Bruban V; Bousquet P; Feldman J
Neuropharmacology; 2002 Dec; 43(8):1330-8. PubMed ID: 12527483
[TBL] [Abstract][Full Text] [Related]
11. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
[TBL] [Abstract][Full Text] [Related]
12. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
Szabo B; Urban R
Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
[TBL] [Abstract][Full Text] [Related]
13. Central imidazoline receptors and centrally acting anti-hypertensive agents.
Head GA; Burke SL; Chan CK
Clin Exp Hypertens; 1997; 19(5-6):591-605. PubMed ID: 9247741
[TBL] [Abstract][Full Text] [Related]
14. alpha 2A-adrenoceptors, not I1-imidazoline receptors, mediate the hypotensive effects of rilmenidine and moxonidine in conscious mice. In vivo and in vitro studies.
Zhu QM; Lesnick JD; Jasper JR; MacLennan SJ; Dillon MP; Eglen RM; Blue DR
Ann N Y Acad Sci; 1999 Jun; 881():287-9. PubMed ID: 10415927
[No Abstract] [Full Text] [Related]
15. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
Szabo B; Bock C; Nordheim U; Niederhoffer N
Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923
[TBL] [Abstract][Full Text] [Related]
16. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
[TBL] [Abstract][Full Text] [Related]
17. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats.
Estato V; Araújo CV; Bousquet P; Tibiriçá E
Braz J Med Biol Res; 2004 Oct; 37(10):1541-9. PubMed ID: 15448876
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits.
Godwin SJ; Tortelli CF; Parkin ML; Head GA
J Auton Nerv Syst; 1998 Oct; 72(2-3):195-204. PubMed ID: 9851569
[TBL] [Abstract][Full Text] [Related]
19. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits.
Parkin ML; Godwin SJ; Head GA
J Hypertens; 2003 Jan; 21(1):167-78. PubMed ID: 12544449
[TBL] [Abstract][Full Text] [Related]
20. Involvement of imidazoline receptors in the baroreflex effects of rilmenidine in conscious rabbits.
Head GA; Burke SL; Sannajust FJ
J Hypertens; 2001 Sep; 19(9):1615-24. PubMed ID: 11564982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
